Search research articles
Contact Us
Filters
Showing results (11-20 of 279) with videos related to
Page
of 28
Sort By:
Current Alzheimer Research
|
April 7, 2018
Differential Cued-Stroop Performance in Cognitively Asymptomatic Older Adults with Biomarker-Identified Risk for Alzheimer's Disease: A Pilot Study
Ryan Van Patten, Anne M Fagan, David A S Kaufman
Journal of Alzheimer'S Disease : JAD
|
March 12, 2016
Spatial Navigation in Preclinical Alzheimer's Disease
Samantha L Allison, Anne M Fagan, John C Morris, et al.
Journal of Alzheimer'S Disease : JAD
|
March 25, 2006
The search for antecedent biomarkers of Alzheimer's disease
Anne M Fagan, Cynthia A Csernansky, John C Morris, et al.
The Journal of Biological Chemistry
|
December 27, 2002
Novel role for apolipoprotein E in the central nervous system. Modulation of sulfatide content
Xianlin Han, Hua Cheng, John D Fryer, et al.
Neurobiology of Aging
|
January 21, 2012
Toward a multifactorial model of Alzheimer disease
Martha Storandt, Denise Head, Anne M Fagan, et al.
Genome Medicine
|
December 12, 2022
Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes
Chengran Yang, Anne M Fagan, Richard J Perrin, et al.
Molecular & Cellular Proteomics : MCP
|
October 4, 2005
Comparative proteomic analysis of intra- and interindividual variation in human cerebrospinal fluid
Yan Hu, James P Malone, Anne M Fagan, et al.
Journal of Alzheimer'S Disease : JAD
|
December 28, 2020
Identifying Preclinical Alzheimer's Disease Using Everyday Driving Behavior: Proof of Concept
Ganesh M Babulal, Ann Johnson, Anne M Fagan, et al.
Alzheimer Disease and Associated Disorders
|
December 30, 2021
Limited Longitudinal Change in Self-reported Spatial Navigation Ability in Preclinical Alzheimer Disease
Taylor F Levine, Catherine M Roe, Ganesh M Babulal, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 6, 2014
Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
Kaj Blennow, Bruno Dubois, Anne M Fagan, et al.
Page
of 28
Search research articles
Search
Showing results (11-20 of 279) with videos related to
Sort By:
Page
of 28
Current Alzheimer Research
|
April 7, 2018
Differential Cued-Stroop Performance in Cognitively Asymptomatic Older Adults with Biomarker-Identified Risk for Alzheimer's Disease: A Pilot Study
Ryan Van Patten, Anne M Fagan, David A S Kaufman
Journal of Alzheimer'S Disease : JAD
|
March 12, 2016
Spatial Navigation in Preclinical Alzheimer's Disease
Samantha L Allison, Anne M Fagan, John C Morris, et al.
Journal of Alzheimer'S Disease : JAD
|
March 25, 2006
The search for antecedent biomarkers of Alzheimer's disease
Anne M Fagan, Cynthia A Csernansky, John C Morris, et al.
The Journal of Biological Chemistry
|
December 27, 2002
Novel role for apolipoprotein E in the central nervous system. Modulation of sulfatide content
Xianlin Han, Hua Cheng, John D Fryer, et al.
Neurobiology of Aging
|
January 21, 2012
Toward a multifactorial model of Alzheimer disease
Martha Storandt, Denise Head, Anne M Fagan, et al.
Genome Medicine
|
December 12, 2022
Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes
Chengran Yang, Anne M Fagan, Richard J Perrin, et al.
Molecular & Cellular Proteomics : MCP
|
October 4, 2005
Comparative proteomic analysis of intra- and interindividual variation in human cerebrospinal fluid
Yan Hu, James P Malone, Anne M Fagan, et al.
Journal of Alzheimer'S Disease : JAD
|
December 28, 2020
Identifying Preclinical Alzheimer's Disease Using Everyday Driving Behavior: Proof of Concept
Ganesh M Babulal, Ann Johnson, Anne M Fagan, et al.
Alzheimer Disease and Associated Disorders
|
December 30, 2021
Limited Longitudinal Change in Self-reported Spatial Navigation Ability in Preclinical Alzheimer Disease
Taylor F Levine, Catherine M Roe, Ganesh M Babulal, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 6, 2014
Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
Kaj Blennow, Bruno Dubois, Anne M Fagan, et al.
Page
of 28